C-reactive protein and platelet-lymphocyte ratio as potential tumor markers in low-alpha-fetoprotein hepatocellular carcinoma
A Suner, BI Carr, H Akkiz, G Karakülah, O Üsküdar… - Oncology, 2018 - karger.com
The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …
C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma
A Suner, BI Carr, H Akkiz, G Karakülah… - …, 2019 - pubmed.ncbi.nlm.nih.gov
The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …
C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma
A SUNER KARAKÜLAH, B Carr, H AKKIZ… - …, 2019 - avesis.hacettepe.edu.tr
The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …
C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma
A SUNER KARAKÜLAH, B Carr, H AKKIZ… - …, 2019 - avesis.deu.edu.tr
The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …
C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma
A Suner, BI Carr, H Akkiz, G Karakülah, O Üsküdar… - Oncology, 2018 - karger.com
The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …
C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma
A SUNER KARAKÜLAH, B Carr, H AKKIZ… - …, 2019 - avesis.inonu.edu.tr
The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …
C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma
A SUNER KARAKÜLAH, B Carr, H AKKIZ… - ONCOLOGY, 2019 - avesis.cu.edu.tr
The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …
C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma.
A SUNER KARAKÜLAH, B Carr, H AKKIZ… - Oncology, 2019 - avesis.ogu.edu.tr
The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …
C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma.
A Suner, BI Carr, H Akkiz, G Karakülah… - …, 2018 - search.ebscohost.com
The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …
in about half of the HCC patients, limiting its usefulness in following the effects of therapy or …